Alembic

Alembic Pharmaceuticals receives USFDA approval for Nifedipine tablets | Tech Reddy

by

[ad_1] Alembic Pharmaceuticals Limited has announced that it has received final USFDA approval for its Abbreviated New Drug Application (ANDA) for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg. USFDA approved ANDA therapeutically approved by Pfizer Inc. equivalent to the company’s Procardia XL Extended-Release tablets, 30 mg, 60 mg and 90 mg. … Read more

Alembic Pharma Gets USFDA Nod for Nifedipine Extended Release Tablets | Tech Reddy

by

[ad_1] Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, according to IQVIA, the estimated market size for the twelve months ending September 2022 is USD 56 million. Alembic Pharmaceuticals Limited (Alembic) announced today that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug … Read more